PhD student
Zhejiang University, China (People's Republic)
Wei Liu, a PhD candidate in the School of Pharmacy, Zhejiang University. Liu focuses on modifying insulin and developing advanced glucose-responsive insulin delivery systems for the treatment of diabetes. She has published more than 10 peer-reviewed papers. She has participated in the Juvenile Diabetes Research Foundation projects and participated in the preclinical trials related to the IND declaration.
